Eastman R C, Gorden P, Roth J
J Clin Endocrinol Metab. 1979 Jun;48(6):931-40. doi: 10.1210/jcem-48-6-931.
Forty-seven acromegalic patients were treated with conventional supervoltage irradiation (4000-5000 rads) and were followed-up at 2, 5, and 10 yr after treatment. The mean fall in the GH concentrations 5 years after treatment was 77%, and GH was less than 10 ng/ml in 73% of the cases. In the majority, GH continued to fall over the 5- to 10-yr interval after treatment, so that by 10 yr, plasma GH was less than or equal to 10 ng/ml in 81% and less than or equal to 5 ng/ml in 69% of the patients. Also, the subjective (acral and facial changes) and the objective (metabolic) effects of GH excess all showed significant improvement with time, and the improvement roughly paralleled the fall in plasma GH concentrations. After therapy, no patient developed extrasellar extension, and headaches improved in the majority of patients. The prevalence of hypopituitarism, which was low before treatment, increased progressively throughout the follow-up period. Significant loss of vision was observed in only one patient, who received 5600 rads and had severe systemic sarcoidosis. The only other complication was temporal hair loss. Conventional super-voltage irradiation by 5-10 yr produces the same fall in plasma GH as all other forms of treatment for acromegaly, including transphenoidal microsurgery. The rate of fall in plasma GH after conventional irradiation is comparable to that of more aggressive forms of irradiation and is slower than that achieved by surgical methods but probably conventional irradiation has fewer serious side effects.
47例肢端肥大症患者接受了常规超高压照射(4000 - 5000拉德),并在治疗后2年、5年和10年进行随访。治疗后5年生长激素(GH)浓度平均下降77%,73%的病例中GH低于10 ng/ml。大多数情况下,治疗后5至10年间GH持续下降,因此到10年时,81%的患者血浆GH小于或等于10 ng/ml,69%的患者小于或等于5 ng/ml。此外,GH过多引起的主观(肢端和面部改变)和客观(代谢)效应均随时间显著改善,且改善情况大致与血浆GH浓度下降平行。治疗后,无一例患者出现鞍外扩展,大多数患者头痛改善。垂体功能减退的患病率在治疗前较低,在整个随访期间逐渐升高。仅1例患者出现明显视力丧失,该患者接受了5600拉德照射且患有严重全身性结节病。唯一的其他并发症是颞部脱发。5至10年的常规超高压照射使血浆GH下降程度与肢端肥大症的所有其他治疗方式相同,包括经蝶窦显微手术。常规照射后血浆GH的下降速率与更积极的照射方式相当,比手术方法慢,但可能常规照射的严重副作用较少。